Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Chlorpromazine Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 181Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rubicon’s Generics Chlorpromazine HCl Receives Approval in US
    Rubicon’s Generics Chlorpromazine HCl Receives Approval in US

    10 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216678

    FDA
    10 Oct 2025
    Share Share
    Enforcement Report - Week of September 17, 2025
    Enforcement Report - Week of September 17, 2025

    17 Sep 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-17-2025-5582.pdf

    FDA
    17 Sep 2025
    Share Share
    Enforcement Report - Week of September 10, 2025
    Enforcement Report - Week of September 10, 2025

    10 Sep 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-10-2025-82423.pdf

    FDA
    10 Sep 2025
    Share Share
    Enforcement Report - Week of April 16, 2025
    Enforcement Report - Week of April 16, 2025

    16 Apr 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-16-2025-39741.pdf

    FDA
    16 Apr 2025
    Share Share
    Glenmark, Sun Pharma, Zydus recall products in US
    Glenmark, Sun Pharma, Zydus recall products in US

    13 Apr 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-sun-pharma-zydus-recall-products-in-us/articleshow/120248890.cms

    ECONOMICTIMES
    13 Apr 2025
    Share Share
    Piramal surges 4% after launching drug for psychiatric disorders
    Piramal surges 4% after launching drug for psychiatric disorders

    23 Jan 2025

    // BUSINESS STD

    https://www.business-standard.com/markets/news/piramal-pharma-surges-4-after-launching-drug-for-psychiatric-disorders-125012300441_1.html

    BUSINESS STD
    23 Jan 2025
    Share Share